BioCentury | Nov 1, 2019
Product Development

Adrenomed looks beyond immune modulators for sepsis, aims for shock prevention

...developers. Adrenomed plans to pair the mAb with a diagnostic it developed in collaboration with sphingotec...
...the executives formed Adrenomed to apply personalized medicine to the indication. Adrenomed teamed up with sphingotec...
...in Europe and was licensed to Adrenomed. It reads out a result in one hour. sphingotec...
BioCentury | Jun 16, 2016
Translation in Brief

Fat links

...to measure in the clinic or connect directly to human disease. Using an assay from sphingotec...
...It's a very unstable molecule, a small peptide with a half-life of only seconds," said sphingotec...
...prohormone peptide and is released in a one-to-one manner with the active peptide." Using the sphingotec...
BioCentury | Nov 24, 2014
Company News

sphingotec, GeneNews deal

...GeneNews received rights to sphingotec’s breast cancer risk assessment assays, sphingotest pro-NT and sphingotest pro-ENK. GeneNews...
...JV, Innovative Diagnostic Laboratory LLP. GeneNews and sphingotec did not respond to requests for information. sphingotec...
Items per page:
1 - 3 of 3
BioCentury | Nov 1, 2019
Product Development

Adrenomed looks beyond immune modulators for sepsis, aims for shock prevention

...developers. Adrenomed plans to pair the mAb with a diagnostic it developed in collaboration with sphingotec...
...the executives formed Adrenomed to apply personalized medicine to the indication. Adrenomed teamed up with sphingotec...
...in Europe and was licensed to Adrenomed. It reads out a result in one hour. sphingotec...
BioCentury | Jun 16, 2016
Translation in Brief

Fat links

...to measure in the clinic or connect directly to human disease. Using an assay from sphingotec...
...It's a very unstable molecule, a small peptide with a half-life of only seconds," said sphingotec...
...prohormone peptide and is released in a one-to-one manner with the active peptide." Using the sphingotec...
BioCentury | Nov 24, 2014
Company News

sphingotec, GeneNews deal

...GeneNews received rights to sphingotec’s breast cancer risk assessment assays, sphingotest pro-NT and sphingotest pro-ENK. GeneNews...
...JV, Innovative Diagnostic Laboratory LLP. GeneNews and sphingotec did not respond to requests for information. sphingotec...
Items per page:
1 - 3 of 3